Steve Jobs Cancer 2011
Steve Jobs Cancer 2011
Steve Jobs Cancer 2011
Steve Jobs Cancer 2011
Steve Jobs Cancer 2011
Steve Jobs Cancer 2011
Steve Jobs Cancer 2011
Steve Jobs Cancer 2011
Steve Jobs Cancer 2011
Steve Jobs Cancer 2011
Steve Jobs Cancer 2011
Steve Jobs Cancer 2011
Steve Jobs Cancer 2011
Steve Jobs Cancer 2011
Steve Jobs Cancer 2011
Steve Jobs Cancer 2011
Steve Jobs Cancer 2011
Steve Jobs Cancer 2011
Steve Jobs Cancer 2011
Steve Jobs Cancer 2011
Steve Jobs Receiving Treatment At Cancer Clinic Where Patrick Swayze Was Patient
Steve Jobs - who is on another medical leave of absence from Apple, the company he co-founded and manages as its longtime CEO - is receiving treatment at a cancer clinic where Hollywood star Patrick Swayze was a patient in his final days.
PHOTOS: Celebs We Lost In 2010
RadarOnline.com has confirmed Jobs, 55, has been attending the Stanford Cancer Center in Palo Alto, California, where Swayze sought radical chemotherapy for pancreatic cancer before his death in September, 2009.
The skeletal-looking Apple boss was photographed outside the clinic in images set to be published in the next edition of The National Enquirer.
PHOTOS: Celebs With Drinking Problems
In one photo, Jobs is seen getting out of his car at the clinic - a day after he turned in a full day's work when he was spotted on Apple's Cupertino campus.
It's unknown whether Jobs' current health battle is related to his liver transplant from 2009, or whether the pancreatic cancer he previously defeated has returned, or if there is a new problem.
In 2004, the computer genius took time off to recover from surgery to treat a very rare form of pancreatic cancer - called an islet cell neuroendocrine tumor.
PHOTOS: Celebs In Rehab
Jobs, who will turn 56 on February 24, announced on January 17 that he was going on a medical leave.
"At my request, the board of directors has granted me a medical leave of absence so I can focus on my health," Jobs said in an email to employees.
"I will continue as CEO and be involved in major strategic decisions for the company."
No comments:
Post a Comment